Company Overview and News

0
TechnipFMC wins order from HPCL

10h moneycontrol
UK-based energy services company TechnipFMC today said it has been awarded a contract for building one of the units at the Visakhapatnam refinery expansion project of state-owned Hindustan Petroleum Corporation Ltd (HPCL). The firm said it has been awarded a "substantial contract" for a grassroots hydrogen generation unit (HGU) at the refinery. It, however, did not disclose the value of the contract.
HINDPETRO 500104

0
HPCL to automate all its pumping stations by December: Executive Director

2018-07-12 moneycontrol
With an aim to ensure that right quantity and quality of fuel is dispensed at petrol stations, oil marketing company HPCL would automate all its petrol outlets by December, a top company official said here today.
HINDPETRO 500104

0
Oil retailer, aviation stocks spike 4-6% following sharp fall in crude prices

2018-07-12 moneycontrol
Share prices of oil marketing and aviation companies rallied 4-6 percent intraday on Thursday following the sharp correction in crude oil prices in the international markets.
IOC INDIGO BPCL 500547 BRQPY 532617 HINDPETRO JETAIRWAYS 530965 500104 539448

0
Shares of RIL, GAIL Gujarat Gas gain 2-4% as 9th round of City Gas Distribution Scheme gets underway

2018-07-10 moneycontrol
Reliance Industries (RIL), Aegis Logistics, GAIL and Gujarat Gas rallied 2-4 percent intraday on Tuesday as the bidding for the ninth round of City Gas Distribution Scheme closes later today.
IOC 500325 BPCL 500547 RELIANCE 539336 AEGISLOG 530965 532514 IGL GUJGAS BRQPY RIGD GAILY 500003 HINDPETRO GAILF 500104 RLNIY

0
RIL plan to supply jet fuel to Mumbai airport using OMC pipelines faces hurdles

2018-07-08 livemint
Mumbai: State-owned fuel marketers are pushing back against a regulatory suggestion to allow Reliance Industries Ltd (RIL) to use their pipelines to sell jet fuel at the Mumbai airport.
IOC 500325 BPCL 500547 BRQPY RELIANCE RIGD HINDPETRO 530965 500104 RLNIY

0
ONGC gets nod to explore rejig options

2018-07-03 freepressjournal.in
New Delhi : The board of state-owned Oil and Natural Gas Corp (ONGC) has given in-principle approval for exploring options for a restructuring of the group firms including the merger of subsidiaries MRPL and HPCL.
PQRTY HINDPETRO 500104 PETRONET 532522

5
Trade war, boiling oil, falling rupee sink small/mid-caps

2018-06-27 thehindubusinessline
A fall in small- and mid-cap stocks, set off by US President Donald Trump’s trade war mongering, in February that turned into a crash in June has put market traders firmly on the backfoot leading to a sharp decline in volumes.
IOC HINDPETRO 530965 500104

4
HPCL, BPCL, IOC fall 6-8% after Brent crude oil prices spike over $77/bbl

2018-06-27 moneycontrol
The share prices of oil marketing companies ended sharply lower on Wednesday after crude oil prices jumped over $77 a barrel.
IOC BPCL 500547 BRQPY HINDPETRO 530965 500104 500110 CHENNPETRO

1
HPCL-MRPL merger to get board approval in two months: ONGC

2018-06-26 freepressjournal.in
New Delhi : Boards of Hindustan Petroleum Corp and Mangalore Refinery and Petrochemicals may approve the merger of their companies in about two months, Oil and Natural Gas Corp Chairman and Managing Director Shashi Shankar said.
HINDPETRO 500104

4
Adnoc, Aramco sign deal to pick stake in $44-bn refinery

2018-06-26 freepressjournal.in
New Delhi : Abu Dhabi National Oil Company (Adnoc) on Monday signed an initial pact to take a stake in the planned $44-billion refinery in Maharashtra, joining Saudi Aramco which is looking at the project as a vehicle to enter India’s entire energy “value chain” including fuel retailing.
IOC BPCL 500547 BRQPY HINDPETRO 530965 500104

4
$44B India Integrated Project Moves Forward

2018-06-25 rigzone
A proposal to build a refinery and petrochemicals complex at Ratnagiri, on India’s west coast, advanced on Monday.
IOC BPCL 500547 BRQPY HINDPETRO 530965 500104

7
Markets close lower dragged by oil gas stocks; HPCL, BPCL shed 3%, RIL ends in red

2018-06-25 moneycontrol
Benchmark indices ended at day's low with Nifty slipped below 10,800 and Sensex fell over 200 points as selling pressure seen in major banking, pharma and metal names.
IOC 500325 BPCL 500547 RELIANCE 530965 521070 BRQPY RIGD ALOKTEXT HINDPETRO 500104 RLNIY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...